LIXT — Lixte Biotechnology Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Lixte Biotechnology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.6	5.07	4.82	5.35	4.2
Net Total Receivables	0.014	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.67	5.23	5.09	5.56	4.31
Other Long Term Assets
Total Assets	2.67	5.23	5.09	5.56	4.31
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.238	0.217	0.303	0.396	0.314
Total Long Term Debt
Total Debt
Total Liabilities	0.238	0.217	0.303	0.396	0.314
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.43	5.01	4.79	5.17	3.99
Total Liabilities & Shareholders' Equity	2.67	5.23	5.09	5.56	4.31
Total Common Shares Outstanding
Total Preferred Shares Outstanding